ornithine has been researched along with Lung Neoplasms in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (70.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Guan, X; Li, X; Ma, R; Ou, S; Teng, N; Zhao, H | 1 |
| Farina, NH; Hall, EM; Munson, PB; Pass, HI; Shukla, A | 1 |
| Cheng, PN; Ho, JC; Lam, SK; Li, YY; U, KP; Xu, S | 1 |
| Oliver, J; Palou, A; Proenza, AM; Roca, P | 1 |
| Hoekman, K; Musters, RJ; Niessen, HW; Schalkwijk, CG; van Heijst, JW; van Hinsbergh, VW | 1 |
| Burchenal, JH; Warrell, RP | 1 |
| Baylin, SB; Goodwin, G; Luk, GD; Marton, LJ | 1 |
| Bartholeyns, J | 1 |
| Abeloff, MD; Baylin, SB; Griffin, CA; Luk, GD | 1 |
| Hagan, AC; Lachmann, PJ; Mayer, GD; Prakash, NJ; Rosenberger, AL; Sunkara, PS | 1 |
| Bartholeyns, J; Casara, P; Mamont, P | 1 |
| Baylin, SB; Gazdar, AF; Goodwin, G; Luk, GD | 1 |
| Prakash, NJ; Rosenberger, AL; Sunkara, PS | 1 |
| Cakir, E; Gülen, S; Süer Gökmen, S; Yörük, Y; Yorulmaz, F | 1 |
| Baylin, SB; Casero, RA; Luk, GD; Nelkin, BD | 1 |
| Baylin, SB; Luk, GD | 1 |
| Abeloff, MD; Baylin, SB; Luk, GD; McCann, PP; Sjoerdsma, A | 1 |
| Abeloff, MD; Baylin, SB; Luk, GD; Rosen, ST; Sjoerdsma, A; Zeltzman, M | 1 |
| Bepler, G; Carney, DN; Gazdar, AF; Minna, JD; Nau, MM | 1 |
| Algranati, ID; de Lustig, ES; Klein, S; Miret, JJ | 1 |
1 review(s) available for ornithine and Lung Neoplasms
| Article | Year |
|---|---|
Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospects.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; Eflornithine; Esophageal Neoplasms; Guanidines; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Leukemia; Leukemia L1210; Lung Neoplasms; Mice; Mitoguazone; Muscular Diseases; Nausea; Neoplasms; Ornithine; Polyamines; Stilbamidines; Structure-Activity Relationship | 1983 |
1 trial(s) available for ornithine and Lung Neoplasms
| Article | Year |
|---|---|
Methylglyoxal-bis(guanylhydrazone) (Methyl-GAG): current status and future prospects.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Drug Eruptions; Drug Therapy, Combination; Eflornithine; Esophageal Neoplasms; Guanidines; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Leukemia; Leukemia L1210; Lung Neoplasms; Mice; Mitoguazone; Muscular Diseases; Nausea; Neoplasms; Ornithine; Polyamines; Stilbamidines; Structure-Activity Relationship | 1983 |
19 other study(ies) available for ornithine and Lung Neoplasms
| Article | Year |
|---|---|
Construction of the XGBoost model for early lung cancer prediction based on metabolic indices.
Topics: Chromatography, Liquid; Humans; Lung Neoplasms; Ornithine; Palmitoylcarnitine; Tandem Mass Spectrometry | 2023 |
Exosomal miR-16-5p as a target for malignant mesothelioma.
Topics: Aniline Compounds; Antineoplastic Agents; Benzylidene Compounds; Cell Death; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Exosomes; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lung Neoplasms; Maleimides; Mesothelioma; Mesothelioma, Malignant; MicroRNAs; Molecular Targeted Therapy; Ornithine; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Small Molecule Libraries; Transfection | 2019 |
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models.
Topics: Adenocarcinoma; Animals; Apoptosis; Arginase; Arginine; Biomarkers, Tumor; Cell Proliferation; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Ornithine; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Polyethylene Glycols; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Breast and lung cancer are associated with a decrease in blood cell amino acid content.
Topics: Adult; Aged; Amino Acids; Amino Acids, Essential; Asparagine; Blood Cells; Breast Neoplasms; Female; Glutamic Acid; Humans; Lung Neoplasms; Male; Middle Aged; Ornithine; Plasma; Proline; Valine | 2003 |
Argpyrimidine-modified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis.
Topics: Adenocarcinoma; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Caspase 3; Caspases; Enzyme-Linked Immunosorbent Assay; Glucose; Glycation End Products, Advanced; Glycolysis; Heat-Shock Proteins; Humans; Lung Neoplasms; Ornithine; Pyrimidines; Tumor Cells, Cultured | 2006 |
Polyamines are necessary for the survival of human small-cell lung carcinoma in culture.
Topics: Carcinoma, Small Cell; Cell Aggregation; Cell Division; Cell Survival; Cells, Cultured; Eflornithine; Humans; Lung Neoplasms; Ornithine; Polyamines; Putrescine | 1981 |
Treatment of metastatic Lewis lung carcinoma with DL-alpha-difluoromethylornithine.
Topics: Adenosylmethionine Decarboxylase; Animals; Antineoplastic Agents; Eflornithine; Female; Lung; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Polyamines | 1983 |
Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line; Drug Evaluation, Preclinical; Eflornithine; Genetic Variation; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Ornithine; Transplantation, Heterologous | 1983 |
Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Drug Synergism; Eflornithine; Fluorenes; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Ornithine; Poly I-C; Polyamines; Tilorone | 1984 |
Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
Topics: Alkynes; Animals; Antineoplastic Agents; Diamines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Eflornithine; Female; Leukemia L1210; Leukemia P388; Liver Neoplasms, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Ornithine; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred BUF | 1984 |
Growth-inhibitory effects of DL-alpha-difluoromethylornithine in the spectrum of human lung carcinoma cells in culture.
Topics: Antineoplastic Agents; Cell Division; Cell Line; Drug Evaluation, Preclinical; Eflornithine; Humans; Kinetics; Lung Neoplasms; Ornithine | 1982 |
An essential role for polyamines in tumor metastases.
Topics: Animals; Antineoplastic Agents; Cell Division; Eflornithine; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Ornithine; Polyamines | 1982 |
Arginase and ornithine, as markers in human non-small cell lung carcinoma.
Topics: Adenocarcinoma; Aged; Arginase; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung; Lung Neoplasms; Middle Aged; Neoplasm Proteins; Ornithine | 1999 |
Human lung tumor sensitivity to difluoromethylornithine as related to ornithine decarboxylase messenger RNA levels.
Topics: Carcinoma; Carcinoma, Small Cell; Cell Cycle; Cells, Cultured; Eflornithine; Humans; Lung Neoplasms; Ornithine; Ornithine Decarboxylase; Polyamines; Putrescine; RNA, Messenger | 1986 |
Anchorage dependency effects on difluoromethylornithine cytotoxicity in human lung carcinoma cells.
Topics: Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Aggregation; Cell Communication; Cell Survival; Cells, Cultured; Cytoskeleton; Eflornithine; Humans; Lung Neoplasms; Ornithine; Polyamines | 1986 |
Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Topics: Animals; Body Weight; Carcinoma, Small Cell; Cell Aggregation; Eflornithine; Female; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Ornithine; Transplantation, Heterologous | 1986 |
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Small Cell; Colonic Neoplasms; Drug Evaluation; Eflornithine; Female; Gastrointestinal Diseases; Hearing Loss, High-Frequency; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Ornithine; Polyamines | 1986 |
Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line; Dopa Decarboxylase; Dose-Response Relationship, Drug; Eflornithine; Gene Expression Regulation; Humans; Interferon Type I; Lung Neoplasms; Ornithine; Proto-Oncogenes; Recombinant Proteins | 1986 |
Effect of alpha-difluoromethylornithine in lung metastases before and after surgery of primary adenocarcinoma tumors in mice.
Topics: Adenocarcinoma; Animals; Eflornithine; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Ornithine; Polyamines | 1985 |